1. Xiao H, Yu X, Shang Y, Ren R, Xue Y, Dong L, Zhao L, Jiang G, Huang H*.In vitro and intracellular Antibacterial Activity of Sudapyridine (WX-081) against Tuberculosis. Infect Drug Resist. .Infect Drug Resist..2023.2023 Jan 10;16.217-224. |
2. Yu X#,Zhang T#,Kong Y#,Wang F,Dong L,Han M*,Huang H*.Xpert MTB/RIF Ultra outperformed the Xpert assay in tuberculosis lymphadenitis diagnosis: a prospective head-to-head cohort study. . International Journal of Infectious Diseases.2022.122.741-6.SCI |
3. Wang G#, Liang R#, Sun Q, Liao X, Wang C, Huang H*.Extremely high levels of central nervous system involvement in miliary tuberculosis..BMC Infectious Diseases.2022.22(1).417.SCI |
4. Gong Z#,Wang G#,Zeng J,Stojkoska A,Huang H*,Xie J*.Differential DNA Methylomes of clinical MDR, XDR and XXDR Mycobacterium tuberculosis isolates revealed by Using Single-Molecule Real-Time Sequencing.Journal of Drug Targeting.2021.29(1).69-77.SCI |
5. Wen S, Zhang T.Yu X, Dong W,Lan T,Fan J,Xue Y,Wang F,Dong L,Qin S*, Huang H*.The bone penetration of linezolid in osteoarticular tuberculosis patients of China.International Journal of Infectious Diseases.2021.103.364-369.SCI |
6. Huang M#, Wang G#, Sun Q, Jiang G, Li W, Ding Z, Jia H, Gao M, Huang H*, Li Q*.Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in a clinical practice setting of China.Diagn Microbiol Infect Dis.2021.100(1).115306.SCI |
7. Suting Chen#, Tianlu Teng#, Zhuman Zhang, Yuanyuan Shang, Hua Xiao, Guanglu Jiang, Fen Wang, Junnan Jia, Lingling Dong, Liping Zhao, Naihui Chu*, Hairong Huang*.Carbonyl cyanide 3-chlorophenylhydrazone (CCCP) exhibits direct antibacterial activity against Mycobacterium abscessus.Infection and Drug Resistance.2021.14.1199-1208.SCI |
8. Guirong Wang#, Guanglu Jiang#, Wei Jing, Zaojing Zong, Xia Yu, Suting Chen, Weimin Li, Hairong Huang*.Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: A subsequent study of a national survey.J Infect.2021.82(3).371-377.SCI |
9. Shan Gao#, Chong Wang#, Xia Yu#, Tianlu Teng, Yuanyuan Shang, Junnan Jia, Lingling Dong,Liping Zhao, Shuku Liu*, Naihui Chu*, Hairong Huang*.Xpert MTB/RIF Ultra enhances tuberculous pleurisy diagnosis for patients with unexplained exudative pleural effusion who underwent a pleural biopsy via VATS: a prospective cohort study.International Journal of Infectious Diseases.2021.106.370-375.SCI |
10. Guan Liu#, Xia Yu#,JingjingLuo, Yanjie Hu,Lingling Dong, Guanglu Jiang, FengminHuo,Fen Wang,Qian Liang, Hairong Huang*.Mycobacterium vicinigordonae sp.nov.,a slow growing scotochromogenic species isolated from sputum.International Journal of Systematic and Evolutionary Microbiology.2021.71(5). .SCI |
11. Jun Fan#, Tinglong Lan#, Kai Tang#, Guirong Wang#, Weijie Dong, Dawei Li, Guangxuan Yan,Yuan Li, Guohua Lei, Jianlin Shan, Qinglei Wang, Jianhua Ma, Hairong Huang*, Shibing Qin*.The comparative influence of 2 and 4 week preoperative anti-tuberculosis treatment on spinal tuberculosis surgery: a multicenter, prospective randomized clinical trial..Infectious Diseases and Therapy.2021.10(3).1451-1463.SCI |
12. Shu'an Wen#, Xiaopan Gao# , Weijie Zhao#, Fengmin Huo , Guanglu Jiang , Lingling Dong , Liping Zhao , Fen Wang , Xia Yu*, Hairong Huang*.In Vitro efficacy comparison of linezolid, tedizolid, sutezolid and delpazolid against rapid growing Mycobacteria isolated in Beijing, China. Comparison of the in vitro activity of linezolid, tedizolid, sutezolid, and delpazolid against rapidly growing mycobacteria isolated in Beijing, China..Journal of Infectious Diseases.2021.109.253-260.SCI |
13. Zhuman Zhang#, Jian Du#,Tao Liu#, Feng Wang, Junnan Jia, Lingling Dong, Liping Zhao,Yi Xue, Guanglu Jiang, Xia Yu*, Hairong Huang*.EasyNAT MTC Assay: A Simple, Rapid, and Low Cost Cross-Priming Amplification Method for Detection of Mycobacterium Tuberculosis Suitable for Point-of-Care Testing.Emerging Microbes & Infections.2021.10(1).1530-1535.SCI |
14. Xia Yu # , Fengmin Huo # , Fen Wang # , Shu'an Wen , Guanglu Jiang , Yi Xue , Lingling Dong , Liping Zhao , Rui Zhu , Hairong Huang*.In Vitro antimicrobial activity comparison of linezolid, tedizolid, sutezolid and delpazolid against slowly growing Mycobacteria isolated in Beijing, China.Infection and Drug Resistance.2021.2021 Nov 9;14.4689-4697.SCI |
15. Jian Du#, Qing Li#, Min Liu#, Yufeng Wang, Zhongtan Xue, Fengmin Huo, Xuxia Zhang, Yuanyuan Shang, Shanshan Li, Hairong Huang*, Yu Pang*.Distinguishing Relapse From Reinfection With Whole-Genome Sequencing in Recurrent Pulmonary Tuberculosis: A Retrospective Cohort Study in Beijing, China.Front Microbiol.2021.12:754352. .SCI |
16. 于霞#, 任汝颜, 文舒安, 梁倩, 董玲玲, 黄海荣*.13种抗生素对快生长分枝杆菌的体外抑菌效果评价.中国防痨杂志.2021.43 (9).947-951.核心期刊 |
17. Jing W#, Zong Z#,Tang H#,Wang J,Zhang T, Wen S,Xue Y,Chu N*,Zhao W*, Huang H*.Population Pharmacokinetic Analysis of Isoniazid among Pulmonary Tuberculosis Patients from China.Antimicrob Agents Chemother.2020.64(3).e01736-19.SCI |
18. Chen S,Teng T,Wen S,Zhang T, Huang H*.The aceE involves in mycolic acid synthesis and biofilm formation in Mycobacterium smegmatis.The aceE involves in mycolic acid synthesis and biofilm formation in Mycobacterium smegmatis.2020.20(1).259-263.SCI |
19. Jing W, Zong Z,Tang H,Wang J,Zhang T, Wen S,Xue Y,Chu N*,Zhao W*, Huang H*.Population Pharmacokinetic Analysis of Isoniazid among Pulmonary Tuberculosis Patients from China.. Antimicrob Agents Chemother.2020.64(3).-.SCI |
20. Zhou Z#, Li C#, Zhu R#,Wang D, Liu T,Jia J, Wang F,Zhao L,Dong L,Yu X*, Huang H*.Combination of percutaneous lung biopsy and Xpert MTB/RIF Ultra enhances differential diagnosis of tuberculosis: a prospective cohort study.Infectious Diseases and Therapy.2020.9(4).797-806.SCI |
21. Wang G, Wang S, Yang X, Sun Q, Jiang G, Huang M, Huo F, Ma Y, Chen X*, Huang H*.Accuracy of Xpert MTB/RIF Ultra for the diagnosis of pleural tuberculosis in a multicentre cohort study.. Chest.2020.157(2).268-275.SCI |
22. 姜广路,王芬,薛毅,贾俊楠,黄海荣*.奈诺沙星对结核分枝杆菌、胞内分枝杆菌和脓肿分枝杆菌的体外抗菌活性分析.中华结核与呼吸杂志.2020.43(12).1061-5.核心期刊 |
23. Jiao W, Wang Y, Wang G, Wang Y, Xiao Jing, Sun L, Li J, Wen S, Zhang T,Ma Q, Huang H*, Shen A*..Development and clinical validation of multiple cross displacement amplification combined with nanoparticles-based biosensor for detection of Mycobacterium tuberculosis: preliminary results..Front Microbiol. .2019.-.-.SCI |
24. Zhang T, Jiang G, Wen S, Huo F, Wang F, Huang H*, Pang Y*. Para-aminosalicylic acid increases the susceptibility to isoniazid in clinical isolates of Mycobacterium tuberculosis. .Infect Drug Resist.2019.12.825-829.SCI |
25. Sun Q, Wang S, Dong W, Jiang G, Huo F, Ma Y, Huang H*, Wang G*. Diagnostic value of Xpert MTB/RIF Ultra for osteoarticular tuberculosis. .J Infect. .2019.79(2).153-158.SCI |
26. Huang H#, Ding N#, Yang T#, Li C#, Jia X#, Wang G#, Zhong J, Zhang J, Jiang G, Wang S, Zong Z, Jing W, Zhao Y, Xu S*, Chen F*.Cross-sectional whole-genome sequencing and epidemiological study of multidrug-resistant Mycobacterium tuberculosis in China..Clin Infect Dis.2019.65.405-413.SCI |
27. Sun L, Zhang L, Wang T, Jiao W, Li Q, Yin Q, Li J, Qi H, Xu F, Shen C, Xiao J, Liu S, Mokrousov I*, Huang H*, Shen A*. Mutations of Mycobacterium tuberculosis induced by anti-tuberculosis treatment result in metabolism changes and elevation of ethambutol resistance..Infect Genet Evol.2019.72.151-158.SCI |
28. Dai G#, Chen S#, Dong L,Huo F, Shang Y,Huang H*.Determination of the critical concentration of rifabutin for susceptibility testing using the proportion method with Löwenstein-Jensen medium against Mycobacterium tuberculosis isolates.. Lab Medicine.2019.50(3).292-297.SCI |
29. Wen S, Jing W, Zhang T, Zong Z, Xue Y, Shang Y, Wang F, Huang H*, Chu N*, Pang Y*.Comparison of in vitro activity of the nitroimidazoles delamanid and pretomanid against multidrug-resistant and extensively drug-resistant tuberculosis..Eur J Clin Microbiol Infect Dis.2019.38(7).1293-1296.SCI |
30. Wang G#, Wang S#, Jiang G#, Yang X#,Huang M, Huo F,Ma Y, Dai G, Li W, Chen X*, Huang H*.Xpert MTB/RIF Ultra improved the diagnosis of paucibacillary tuberculosis: a prospective cohort study. .J Infect.2019.78(4).311-316.SCI |
31. Liu R, Liang Q, Shang Y, Ma Y, Wang F, Dong L, Huang H*, Gao M*, Pang Y*.GeneXpert of stool versus gastric lavage fluid for the diagnosis of pulmonary tuberculosis in severely ill adults..Infection.2019.47(4).611-616.SCI |
32. Pang Y, Jing W, Lu J, Zong Z, Huo F, Dong L, Dai G, Li Y, Huang H*, Chu N*.No in vitro synergistic effect of bedaquiline combined with fluoroquinolones, linezolid, and clofazimine against extensively drug-resistant tuberculosis..Diagn Microbiol Infect Dis..2019.94(4).361-364.SCI |
33. Yu X, Gao X, Li C, Luo J,Wen S ,Zhang Z, Ma Y,Dong L,Wang F, Huang H*.In Vitro Activity of bedaquiline and delamanid against Non-tuberculous Mycobacteria isolated in Beijing, China.. AAC.2019.63(8).-.SCI |
34. Huo F, Luo J, Shi J, Zong Z, Wei Jing, Wenzhu Dong,Lingling Dong,Yifeng Ma, Qian Liang,Yuanyuan Shang, Huang H*, Yu Pang . Increasing Prevalence of Rifampicin-Resistant Mycobacterium tuberculosis is Associated with the Transmission of Strains Harboring Compensatory Mutations in China: A 10-year Comparative Analysis .Antimicrob Agents Chemother .2018.62(4) . .SCI |
35. Tan J#,Wu X#,Chen S,Gu M, Huang H*,Yue W* .Dominant epitopes derived from cell-wall protein LppZ for immunodiagnostic ofpulmonary tuberculosis.BMC Immunology .2018.19(1).10.SCI |
36. Wang Q, Pang Y, Jing W, Liu Y, Wang N, Yin H, Zhang Q, Ye Z, Zhu, M, Li M, Liu P, Wu T, Chen C, Wu W, Qin Z, Qiu C, Deng Q, Xu T, Wang J, Guo R, Du Y, Wang J, Huang H*, Chen X, Chu N. Clofazimine for Treatment of Pulmonary Extensively Drug-Resistant Tuberculosis in China .Antimicrob Agents Chemother.2018. . .SCI |
37. Wang G, Wang S, Jiang G, Fu Y, Shang S, Huang H* . Incremental cost-effectiveness of the second Xpert MTB/RIF assay to detect Mycobacterium tuberculosis .Journal of Thoracic Disease .2018.10(3).1689-1695 .SCI |
38. Wu X, Pang Y, Song Y, Dong W, Zhang T, Wen S, Huang H*, Gao M* . Implications of a school outbreak of multidrug-resistant tuberculosis in Northern China .Epidemiol Infect .2018.146(5).584-588 .SCI |
39. Xia Yu#, Xiling Zeng#, Wenhui Shi, Yanjie Hu, Wenjuan Nie, Naihui Chu*, Huang H*.Validation of Cycloserine Efficacy in Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Beijing, China.Antimicrob Agents Chemother .2018.62(3) . .SCI |
40. Luo J#,Yu X#, Jiang G, Fu Y, Huo F, Ma Y,Wang F, Shang Y, Liang Q, Xue Y, Huang H*.In Vitro Activity of Clofazimine against Nontuberculous Mycobacteria in China. Antimicrob.Antimicrob. Agents Chemother.2018.62(7).-.SCI |
41. Zong Z#, Jing W#, Shi J, Wen S, Zhang T, Huo F, Shang Y, Liang Q, Huang H*, Pang Y*. .Comparison of in vitro activity and MIC distributions between the novel oxazolidinone delpazolid and linezolid against multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in China. .Antimicrob Agents Chemother.2018.62(8).-.SCI |
42. Shi J#, Dong W#, Ma Y, Liang Q, Shang Y, Wang F, Huang H*, Pang Y*..GeneXpert MTB/RIF Outperforms Mycobacterial Culture in Detecting Mycobacterium tuberculosis from Salivary Sputum. .Biomed Res Int.2018.-.-.SCI |
43. Shi J#, Lu J#, Wen S, Zong Z, Huo F, Luo J, Liang Q, Li Y, Huang H*, Pang Y*. .In vitro activity of PBTZ169 against multiple Mycobacterium species. .Antimicrob Agents Chemother.2018.62(11).-.SCI |
44. Zong Z#, Huo F#, Shi J, Jing W, Ma Y, Liang Q, Jiang G, Dai G, Huang H*, Pang Y*.. Relapse Versus Reinfection of Recurrent Tuberculosis Patients in a National TuberculosisSpecialized Hospital in Beijing, China.. Front Microbiol..2018.9.-.SCI |
45. Yang T#,Zhong J#, Zhang J#, Li C, Yu X, Xiao J, Jia X, Ding N, Ma G, Wang G,Yue L, Liang Q, Sheng Y, Sun Y, Huang H*, Chen F*.Pan-genomic study of Mycobacterium tuberculosis reflecting the primary/secondary genes, generality/individuality, and the interconversion through copy number variations. Frontiers in Microbiology.2018.10.-.SCI |
46. Wang G#, Dong W#, Lan T, Fan J,Tang K, Li Y,Yan G,Jiang G, Ma Y, Shang Y, Qin S*, Huang H*.Diagnostic accuracy evaluation of the conventional and molecular tests for Spinal Tuberculosis in a cohort, head-to-head study. .Emerging Microbes & Infections.2018.7(1).109-117.SCI |
47. Li H,Wang X,Wang B,Fu L,Liu G,Lu Y,Cao M,Huang H*, Javid B*.Latently and uninfected healthcare workers exposed to tuberculosis make protective antibodies against Mycobacterium tuberculosis.PNAS.2017. . .SCI |
48. Li QJ, Jiao WW, Yin QQ, Li YJ, Li JQ, Xu F, Sun L, Xiao J, Qi H, Wang T, Mokrousov I, Huang H*, Shen AD*.Positive epistasis of major low-cost drug resistance mutations rpoB531-TTG and katG315-ACC depends on the phylogenetic background of mycobacterium tuberculosis strains..Int J Antimicrob Agents.2017.-.-.SCI |
49. Zeng X, Jing W, Zhang Y, Duan H, Lu Y, Dong Q, Huang H*, Chu N*.Performance of the MTBDRsl Line probe assay for rapid detection of resistance to second-line anti-tuberculosis drugs and ethambutol in China. .Diagn Microbiol Infect Dis.2017.89(2).112-117.SCI |
50. Jia X, Yang L, Dong M, Chen S, Lv L, Cao D,Fu J, Yang J, Zhang J, Zhang X, Shang Y, Wang G, Sheng Y, Huang H*, Chen F.The bioinformatics analysis of comparative genomics of Mycobacterium tuberculosis complex (MTBC) provides insight into dissimilarities between intraspecific groups differing in host association, virulence and epitope diversity.Frontiers in Cellular and Infection Microbiology.2017.7.88.SCI |
51. Chen S,Han Y,Yu D,Huo F,Wang F,Li Y,Dong L,Liu Z,Huang H*.Transdermal delivery of isoniazid and rifampin in guinea pigs by electro-phonophoresis.Drug Deliv.2017.24:1.467-470.SCI |
52. Chen H#, He L#, Huang H#, Shi C, Ni X, Dai G, Ma L, Li W.Mycobactrium tuberculosis Lineage Distribution in Xinjiang and Gansu Provinces, China.. Sci Rep.2017.7(1).1068.SCI |
53. Jing W#, Pang Y#, Zong Z, Wang J, Guo R, Huo F, Jiang G, Ma Y, Huang H*, Chu N*.Rifabutin Resistance Associated with Double Mutations in rpoB Gene in Mycobacterium tuberculosis Isolates.Front Microbiol.2017.8.1768.SCI |
54. Pang Y#, Lu J, Huo F, Ma Y, Zhao L, Li Y, Liang Q, Chu N, Gao M, Huang H*.Prevalence and treatment outcome of extensively drug-resistant tuberculosis plus additional drug resistance from the National Clinical Center for Tuberculosis in China: A five-year review.J Infect.2017.75(5).433-440.SCI |
55. Pang Y#, Zong Z#, Huo F, Jing W, Ma Y, Dong L, Li Y, Zhao L, Fu Y, Huang H*.In vitro drug susceptibility of bedaquiline, delamanid, linezolid, clofazimine, moxifloxacin, and gatifloxacin against extensively drug –resistant tuberculosis from Beijing, China.Antimicrob Agents Chemother.2017.61(10). .SCI |
56. Pang Y#, Shang Y#, Lu J, Liang Q, Dong L, Li Y, Zhao L, Jiang G, Huang H*.GeneXpert MTB/RIF assay in the diagnosis of urinary tuberculosis from urine specimens.Scientific reports.2017.7(1).6181.SCI |
57. Wei G,Mu J,Wang G,Huo F,Dong L,Li Y, Huang H*.Evaluation of Xpert positive but smear negative culture-negative outcomes for tuberculosis diagnosis.Journal of Thoracic Disease.2016.8(6).1205-9.SCI |
58. Yin QQ, Jiao WW, Li QJ, Xu F, Li JQ, Sun L, Li YJ, Huang HR*, Shen AD*.Prevalence and molecular characteristics of drug-resistant Mycobacterium tuberculosis in Beijing, China: 2006 versus 2012.BMC Microbiol.2016.16 (1).85.SCI |
59. Zeng X, Jing W, Zhang Y, Duan H, Lu Y, Dong Q, Huang H*, Chu N*.Performance of the MTBDRsl Line probe assay for rapid detection of resistance to second-line anti-tuberculosis drugs and ethambutol in China.Diagn Microbiol Infect Dis.2016.(16).30171-7.SCI |
60. Hu Y, Chen S, Yu X, Dai G, Dong L, Li Y, Zhao L, Huang H*.Rapid identification of the NAT2 genotype in tuberculosis patients by multicolor melting curve analysis.Pharmacogenomics.2016.60(5).1211-5.SCI |
61. Yu X, Gu Y, Jiang G, Ma Y, Zhao L, Sun Z, Jain P, O'Donnell M, Larsen M, Jacobs WR Jr, Huang H*.Evaluation of a High-Intensity Green Fluorescent Protein Fluorophage Method for Drug- Resistance Diagnosis in Tuberculosis for Isoniazid, Rifampin, and Streptomycin.Front Microbiol.2016.7.922.SCI |
62. Li QJ, Jiao WW, Yin QQ, Xu F, Li JQ, Sun L, Xiao J, Li YJ, Mokrousov I, Huang HR*, Shen AD*.Compensatory Mutations of Rifampicin Resistance Are Associated with Transmission of Multidrug Resistant Mycobacterium tuberculosis Beijing genotype strains in China.Antimicrob Agents Chemother.2016.60(5).2807-12.SCI |
63. Xie L#, Wang G#, Yu Z, Zhou M, Li Q, Huang H*, Xie J*.Proteome-wide Lysine Glutarylation Profiling of the Mycobacterium tuberculosis H37Rv.J Proteome Res.2016.15(4).1379-85.SCI |
64. Zhang L,Pang Y,Yu X,Wang Y,Gao M,Huang H*,Zhao Y.Risk factors for pulmonary cavitation in tuberculosis patients from China.Emerging Microbes & Infections.2016.5.111.SCI |
65. Wang G, Yang X, Zhu J, Dong W, Huang M, Jiang G, Zhao L, Qin S, Chen X, Huang H*.Evaluation of the efficacy of Myco/F lytic system, MGIT960 system and Lowenstein-Jensen medium for recovery of Mycobacterium tuberculosis from sterile body fluids.Scientific Reports.2016.6.37757.SCI |
66. Chen S#, Qin M#, Han Y, Zhao L, Fu Y, Shang Y, Liu Z, Huang H*.Assessment of the efficacy of drug transdermal delivery by electro-phonophoresis in treating tuberculous lymphadenitis..Drug Deliv.2016.23(5).-.SCI |
67. Duan H,Han X, Wang Q,Wang J,Wang J,Chu N,Huang H*.Clinical Significance of Nontuberculous Mycobacteria Isolated From Respiratory Specimens in a Chinese Tuberculosis Tertiary Care Center.Scientific Reports.2016.6.36299.SCI |
68. Lingxiang Zhu#,Jun Zhong#,Xinmiao Jia#,Guan Liu#,Yu Kang#,Mengxing Dong,Xiuli Zhang,Qian Li,Liya Yue,Cuidan Li, Jing Fu,Jingfa Xiao,Jiangwei Yan,Bing Zhang,Meng Lei,Suting Chen,Lingna Lv,Baoli Zhu,Hairong Huang*, Fei Chen*.Precision methylome characterization of Mycobacterium tuberculosis complex (MTBC) using PacBio single-molecule real-time (SMRT) technology.Nucleic Acids Research.2016.44(2).730-743.SCI |
69. Gu Y#,Yu X#,Jiang G,Wang X,Ma Y,Li Y, Huang H*.Pyrazinamide resistance among multidrug-resistant tuberculosis clinical isolates in a national referral center of China and its correlations with pncA, rpsA and panD gene mutations.Diagn Microbiol Infect Dis..2016.84.207-211.SCI |
70. Yu X, Ma Y, Jiang G, Chen S,Wang G, Huang H*.Evaluation of the Sensititre MYCOTB Plate for Susceptibility Testing of the Mycobacterium tuberculosis Complex Isolates.IJTL.2016.20(3).329-334.SCI |
71. Li X#, Chen L#, Zhu Y, Yu X, Cao J, Wang R,Lv X,He J,Guo A,Huang H*,Zheng H*,Liu S*.Genomic Analysis of a Mycobacterium Bovis bacillus Calmette-Guérin Strain Isolated from an Adult Patient with Pulmonary Tuberculosis.Plos One.2015.10(4).e0122403.SCI |
72. Yu X, Zhao L,Jiang G,Ma Y, Li W,Huang H*.Macrocolonies (granules) formation as a cause of false-negative results in the MGIT 960 System. Cause analysis and correlation with Mycobacterial species.BioMed Res Int.2015. .501874.SCI |
73. Wei G,Huang M,Wang G,Huang H*.Antimicrobial Susceptibility Testing and Genotyping of Mycobacterium avium isolates of Two Tertiary Tuberculosis designated Hospital, China.Infect Genet Evol.2015.36.141-146.SCI |
74. Li XY, Li Y, Zhang Y, Kang WL, Zhao LP, Ding PJ, Dai WT, Huang HR*, Huang YF*, Li WM*.The Epidemiological Characteristics of Beijing Lineage Mycobacterium tuberculosis from a National Referral Center in China.Biomed Environ Sci.2015.28(7).539-43..SCI |
75. Chen S#, Qin M#, Han Y, Zhao L, Fu Y, Shang Y, Liu Z, Huang H*.Assessment of the efficacy of drug transdermal delivery by electro-phonophoresis in treating tuberculous lymphadenitis..Drug Deliv.2015.22(8).1-6.SCI |
76. Gu Y#,Wang G#,Dong W,Li Y,Ma Y,Shang Y,Qin S*,Huang H*. Xpert MTB/RIF and GenoType MTBDRplus assay for Rapid Diagnosis of Bone and Joint Tuberculous. International journal of infectious diseases.Int J Infect Dis. .2015.36.27-30.SCI |
77. Chen S, Zhao L, Dong W, Gu Y, Li Y, Dong L, Ma Y, Qin S, Huang H*.The Clinical Features and Bacteriological Characterizations of Bone and Joint Tuberculosis in China.Sci Rep..2015.5.11084.SCI |
78. Nie W,Duan H,Huang H*,Lu Y,Chu N*. Species Identification and Clarithromycin Susceptibility Testing of 278 Clinical Nontuberculosis Mycobacteria Isolates.BioMed Res Int.2015.6.506598.SCI |
79. Liu Guan#, Chen Suting#, Yu Xia, Li Yunxu, Ling Ying, Dong Lingling, Zheng Suhua*, Huang Hairong*.Bacteriological and virulence study of a Mycobacterium Chimaera isolate from a patient in China.Antonie Van Leeuwenhoek.2015.107(4).901-909.SCI |
80. Li H#, Kayani MU#, Gu Y#, Wang X, Zhu T, Duan H, Ma Y, Huang H*, Javid B*.Transmitted Extended-Spectrum Extensively Drug-Resistant Tuberculosis in Beijing, China, with Discordant Whole-Genome Sequencing Analysis Results.J Clin Microbiol.2015.53(8).2781-4.SCI |
81. Zhang X#, Liu L#, Zhang Y#,Dai G, Huang H* , Jin Q*.Genetic Determinants Involved in p-Aminosalicylic Acid Resistance in Clinical Isolates from Tuberculosis Patients in Northern China from 2006 to 2012.Antimicrobial Agents and Chemotherapy.2015.59(2).1320-1324.SCI |
82. Jiang, G#. Wang G#,Cheng S,Yu X,Wang X,Zhao L,Ma Y,Dong L,Huang H*.Pulmonary Tuberculosis Caused by Mycobacterium bovis in China.Sci. Rep..2015.5.1-3.SCI |
83. Zhang L#, Pang Y#, Yu X#, Wang Y, Gao M*, Huang H* ,Zhao Y*.Linezolid in the treatment of extensively drug-resistant tuberculosis. .Infection.2014.42(4).705-11..SCI |
84. Liu Guan#, Chen Suting#, Yu Xia, Li Yunxu, Ling Ying, Dong Lingling, Zheng Suhua*, Huang Hairong* .Bacteriological characterization of a Mycobacterium parascrofulaceum strain isolated from a Chinese pneumonia patient. .Int J Infect Dis. .2014.25.82-87.SCI |
85. Wang X, Zhao L, Yu X, Li Y, Ma Y, Dong L, Huang H*.Bead capture increases the sensitivity of sputum microscopy for the diagnosis of tuberculosis in Beijing, China..T ROY SOC TROP MED H.2013.107(11).741-743.SCI |
86. Long Q,Li W,Du Q, Fu Y,Liang Q, Huang H*,Xie J*.GyrA/B fluoroquinolone-resistant allele profiles among Mycobacterium tuberculosis isolates from Mainland China.. International Journal of Antimicrobial Agents.2012.39(6).486-489.SCI |
87. Yu X, Jiang G, Li H, Zhao Y, Zhang H, Zhao L, Ma Y, Coulter C, Huang H*..Rifampicin stability in 7H9 broth and Lowenstein-Jensen medium..Journal of Clinical Microbiology.2011.48(3).0095-1137.SCI |
88. Huang H, Berg S, Spencer J, Vereecke D, D’Haeze D, Holsters M, McNeil M*..Identification of cytoplasmic and transmembrane domains required for catalytic activity of 5-phospho-D-ribose-1-diphosphate: decaprenyl-phosphate 5-phosphoribosyltransferase.Microbiol-SGM.2008.154(3).736-743.SCI |
89. Huang H, Scherman MS, D'Haeze W, Vereecke D, Holsters M, Crick DC, McNeil MR*.Identification and active expression of the Mycobacterium tuberculosis gene encoding 5-phospho-{alpha}-d-ribose-1-diphosphate: decaprenyl-phosphate 5-phosphoribosyltransferase, the first enzyme committed to decaprenylphosphoryl-d-arabinose synthesis. .J Biol Chem. .2005.280(26).24539-43.SCI |
90. Mikusova K, Huang H, Yagi T, Holsters M, Vereecke D, D'Haeze W, Scherman MS, Brennan PJ, McNeil MR, Crick DC.. Decaprenylphosphoryl arabinofuranose, the donor of the D-arabinofuranosyl residues of mycobacterial arabinan, is formed via a two-step epimerization of decaprenylphosphoryl ribose..J Bacteriol..2005.187(23).8020-8025.SCI |